Next Article in Journal
Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
Next Article in Special Issue
A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma
Previous Article in Journal
Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy
Previous Article in Special Issue
siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(7), 1379; https://doi.org/10.3390/pharmaceutics14071379
Action Date Notes Link
article pdf uploaded. 29 June 2022 17:20 CEST Version of Record https://www.mdpi.com/1999-4923/14/7/1379/pdf-vor
article supplementary file uploaded. 29 June 2022 17:20 CEST - https://www.mdpi.com/1999-4923/14/7/1379#supplementary
article xml file uploaded 1 July 2022 13:39 CEST Original file -
article xml uploaded. 1 July 2022 13:39 CEST Update https://www.mdpi.com/1999-4923/14/7/1379/xml
article pdf uploaded. 1 July 2022 13:39 CEST Updated version of record https://www.mdpi.com/1999-4923/14/7/1379/pdf
article html file updated 1 July 2022 13:40 CEST Original file -
article supplementary file uploaded. 4 July 2022 07:42 CEST - https://www.mdpi.com/1999-4923/14/7/1379#supplementary
article html file updated 4 July 2022 07:44 CEST Update -
article html file updated 12 August 2022 23:20 CEST Update https://www.mdpi.com/1999-4923/14/7/1379/html
Back to TopTop